RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 55 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $621,795 | +39.0% | 27,123 | 0.0% | 0.01% | +66.7% |
Q2 2023 | $447,258 | +58.8% | 27,123 | +11.0% | 0.00% | +50.0% |
Q1 2022 | $281,572 | +83.5% | 24,442 | +59.0% | 0.00% | +100.0% |
Q4 2021 | $153,413 | -23.6% | 15,372 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $200,758 | -33.3% | 15,372 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $300,984 | -7.9% | 15,372 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $326,962 | -28.5% | 15,372 | 0.0% | 0.00% | -40.0% |
Q4 2020 | $457,010 | +37.2% | 15,372 | 0.0% | 0.01% | +25.0% |
Q3 2020 | $333,111 | -2.8% | 15,372 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $342,796 | +67.3% | 15,372 | +14.2% | 0.00% | +33.3% |
Q1 2020 | $204,937 | -33.7% | 13,465 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $309,156 | +27.2% | 13,465 | +19.6% | 0.00% | 0.0% |
Q3 2019 | $243,017 | -1.9% | 11,256 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $247,630 | +45.9% | 11,256 | +81.8% | 0.00% | +50.0% |
Q1 2019 | $169,723 | +2.0% | 6,192 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $166,441 | -7.9% | 6,192 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $180,621 | -37.1% | 6,192 | -37.2% | 0.00% | -33.3% |
Q4 2017 | $287,000 | – | 9,862 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |